NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free RDNT Stock Alerts $48.83 +1.18 (+2.48%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$47.73▼$49.1950-Day Range$37.53▼$49.2352-Week Range$25.11▼$49.94Volume348,977 shsAverage Volume522,593 shsMarket Capitalization$3.34 billionP/E RatioN/ADividend YieldN/APrice Target$53.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get RadNet alerts: Email Address RadNet MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside9.9% Upside$53.67 Price TargetShort InterestBearish4.32% of Shares Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment0.67Based on 9 Articles This WeekInsider TradingN/AProj. Earnings Growth48.57%From $0.35 to $0.52 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.17 out of 5 starsMedical Sector322nd out of 909 stocksMedical Laboratories Industry9th out of 19 stocks 1.3 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.32% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in RadNet has recently increased by 6.86%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 2.6 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for RadNet this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.43% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 48.57% in the coming year, from $0.35 to $0.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -2,440.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -2,440.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 4.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About RadNet Stock (NASDAQ:RDNT)RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More RDNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDNT Stock News HeadlinesApril 22, 2024 | globenewswire.comRadNet, Inc. Announces Date of its First Quarter 2024 Financial Results Conference CallApril 22, 2024 | americanbankingnews.comAnalyzing RadNet (NASDAQ:RDNT) & Akumin (NASDAQ:AKUMQ)April 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 18, 2024 | globenewswire.comRadNet Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing TransactionApril 18, 2024 | finance.yahoo.comRadNet’s Delaware Imaging Network Announces Ribbon-Cutting Ceremony for Mammography Service at Milford WalmartApril 18, 2024 | globenewswire.comRadNet's Delaware Imaging Network Announces Ribbon-Cutting Ceremony for Mammography Service at Milford WalmartApril 17, 2024 | finance.yahoo.comRadNet, Inc. (RDNT)April 13, 2024 | americanbankingnews.comRadNet (NASDAQ:RDNT) Rating Lowered to Sell at StockNews.comApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 12, 2024 | globenewswire.comRadNet Teams Up with Basketball Icon Sheryl Swoopes to Promote Healthcare Equity and AccessApril 11, 2024 | investing.comRadNet expands Houston footprint with new acquisitionApril 11, 2024 | msn.comRadNet prices and upsizes refinancing transactionsApril 11, 2024 | globenewswire.comRadNet Announces Pricing and Upsizing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing TransactionApril 10, 2024 | finance.yahoo.comDoes RadNet (RDNT) Have a Long Runway for Growth?April 10, 2024 | globenewswire.comRadNet to Make its Second Acquisition in Houston, TexasApril 8, 2024 | finance.yahoo.comWith 74% ownership, RadNet, Inc. (NASDAQ:RDNT) boasts of strong institutional backingApril 3, 2024 | seekingalpha.comRadNet proposes refinancing its term loan and revolving credit facilityApril 3, 2024 | globenewswire.comRadNet Announces a Proposed Refinancing of its Term Loan and Revolving Credit FacilityApril 2, 2024 | globenewswire.comRadNet Announces Outpatient Radiology Partnership with Providence Health System to Include Seven Centers in Burbank, Santa Clarita and the Northern San Fernando Valley of Los AngelesMarch 28, 2024 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About RadNetMarch 23, 2024 | finance.yahoo.comAt US$48.04, Is It Time To Put RadNet, Inc. (NASDAQ:RDNT) On Your Watch List?March 16, 2024 | finance.yahoo.comRDNT Apr 2024 35.000 putMarch 16, 2024 | finance.yahoo.comRDNT Apr 2024 35.000 callMarch 12, 2024 | globenewswire.comRadNet Announces Closing of Public Offering of Common StockMarch 8, 2024 | msn.comRadNet announces pricing of public offeringMarch 7, 2024 | globenewswire.comRadNet Announces Pricing of Public Offering of Common StockMarch 7, 2024 | globenewswire.comRadNet Announces Proposed $200 Million Underwritten Public Offering of Common StockSee More Headlines Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/01/2024Today4/23/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees10,288Year Founded1980Price Target and Rating Average Stock Price Target$53.67 High Stock Price Target$58.00 Low Stock Price Target$48.00 Potential Upside/Downside+9.9%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E Ratio139.51 P/E GrowthN/ANet Income$3.04 million Net Margins0.19% Pretax Margin2.40% Return on Equity4.72% Return on Assets1.29% Debt Debt-to-Equity Ratio1.00 Current Ratio1.32 Quick Ratio1.32 Sales & Book Value Annual Sales$1.62 billion Price / Sales2.07 Cash Flow$3.50 per share Price / Cash Flow13.97 Book Value$11.79 per share Price / Book4.14Miscellaneous Outstanding Shares68,470,000Free Float65,442,000Market Cap$3.34 billion OptionableOptionable Beta1.69 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Howard G. Berger M.D. (Age 78)Chairman, President & CEO Comp: $5.56MMr. Mark D. Stolper (Age 53)Executive VP & CFO Comp: $1.13MMr. Mital Patel (Age 38)Executive VP of Financial Planning & Analysis and Chief Administrative Officer Comp: $1.15MMr. Norman R. Hames (Age 68)President & COO of Western Operations Comp: $1.28MMr. Stephen M. Forthuber (Age 63)President & COO of Eastern Operations Comp: $1.3MMs. Christine Nayoma Gordon (Age 61)Senior VP of Operations - Northern California & Director Comp: $384.38kMr. Ranjan Jayanathan (Age 68)Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division Dr. Gregory Sorensen M.D. (Age 62)Executive VP, Chief Science Officer & Director Ms. Laura Foster BSRTMPH, J.D., Senior Vice President of Compliance & Regulatory AffairsMr. David Jeffrey Katz (Age 59)Executive VP, Chief Legal Officer & Corporate Secretary More ExecutivesKey CompetitorsFortreaNASDAQ:FTREGuardant HealthNASDAQ:GHVeracyteNASDAQ:VCYTViridian TherapeuticsNASDAQ:VRDNFulgent GeneticsNASDAQ:FLGTView All CompetitorsInsiders & InstitutionsLouisiana State Employees Retirement SystemSold 300 shares on 4/23/2024Ownership: 0.044%Raymond James & AssociatesBought 17,266 shares on 4/22/2024Ownership: 0.136%Maryland State Retirement & Pension SystemBought 1,532 shares on 4/20/2024Ownership: 0.034%State of Alaska Department of RevenueBought 2,697 shares on 4/19/2024Ownership: 0.058%O ROURKE & COMPANY IncBought 5,025 shares on 4/18/2024Ownership: 0.007%View All Insider TransactionsView All Institutional Transactions RDNT Stock Analysis - Frequently Asked Questions Should I buy or sell RadNet stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price target for 2024? 3 brokerages have issued 1 year target prices for RadNet's shares. Their RDNT share price targets range from $48.00 to $58.00. On average, they expect the company's stock price to reach $53.67 in the next year. This suggests a possible upside of 9.9% from the stock's current price. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2024? RadNet's stock was trading at $34.77 at the start of the year. Since then, RDNT shares have increased by 40.4% and is now trading at $48.83. View the best growth stocks for 2024 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our RDNT earnings forecast. How can I listen to RadNet's earnings call? RadNet will be holding an earnings conference call on Thursday, May 9th at 10:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "10188629". How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) announced its earnings results on Friday, March, 1st. The medical research company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.11 by $0.09. The medical research company earned $420.38 million during the quarter, compared to analysts' expectations of $410.11 million. RadNet had a trailing twelve-month return on equity of 4.72% and a net margin of 0.19%. The business's quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.11 earnings per share. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Invesco S&P SmallCap Momentum ETF (XSMO), First Trust Small Cap Growth AlphaDEX Fund (FYC), SPDR S&P 600 Small Cap Growth ETF (SLYG), iShares S&P Small-Cap 600 Growth ETF (IJT) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has RadNet issued on next quarter's earnings? RadNet updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). Who are RadNet's major shareholders? RadNet's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.73%), Raymond James & Associates (0.14%), State of Alaska Department of Revenue (0.06%), Louisiana State Employees Retirement System (0.04%), Maryland State Retirement & Pension System (0.03%) and Contravisory Investment Management Inc. (0.01%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RDNT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
